维升药业启动招股程序 预计集资7.45亿港元

观点新媒体
13 Mar

观点网讯:3月13日,生物制药公司维升药业(2561.HK)宣布启动招股程序,招股期从今日起至下周二(18日),计划发售990万股,其中香港公开发售占10%,其余90%为国际发售。每股招股价介于68.44港元至75.28港元,预计集资总额约7.45亿港元。投资者入场费为7603.92港元,公司股票预计于3月21日在港交所挂牌交易。此次招股所得款项净额将主要用于公司核心产品的开发和商业化。其中,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10